CLICK HERE to listen to this article.
STAT NEWS — Pfizer and BioNTech said Thursday they are beginning a study aimed at showing their Covid-19 vaccine can be used in children as young as 6 months.
The study follows the launch of a separate and ongoing trial in children ages 12 to 15, which was fully enrolled in January. That study could lead to results by the end of the first half of the year, depending on the data, and then to an emergency use authorization. That will depend on the Food and Drug Administration and the Centers for Disease Control and Prevention. The vaccine already has an EUA for people 16 and older
“The FDA, if it sees fit to do this, could, grant an EUA and get them into children in that age group by the fall, provided the CDC also agrees and that that should be the vaccine they receive,” said William Gruber, Pfizer’s senior vice president of vaccine clinical research and development.
Results in younger children would not be expected before the second half of the year, meaning that they could be eligible to receive the vaccine sometime early next year.
PHOTO CREDIT: Vaccines Stock Photos
Support Pierced Hearts blog. See donation options on the home page.